NASDAQ: IMABI Mab Earnings Dates, Reports, Calls
I Mab earnings were -$7.6M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest IMAB earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$3.2M, down 65.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IMAB reported annual earnings of -$22.2M, with -89.3% growth.
IMAB earnings history
Current Revenue
$0.0
Current Earnings
-$7.6M
Current Profit Margin
0%
IMAB Return on Equity
Current Company
-3.5%
Current Industry
-60.2%
Current Market
31.5%
IMAB's Return on Equity (-3.5%)... subscribe to Premium to read more.
High Return on Equity Performance
IMAB undefined
Current Company
-3.3%
Current Industry
-2.5%
IMAB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when IMAB announces earnings.
IMAB undefined
Current Company
-3.77%
Current Industry
5.8%
IMAB vs Biotech Stocks
I Mab Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.